Coronavirus: Incapacity to jab will limit Covid vaccination | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
June 12, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, JUNE 12, 2025
Incapacity to jab will limit Covid vaccination

Covid-19 in Bangladesh

Sadiqur Rahman
06 September, 2020, 11:00 pm
Last modified: 07 September, 2020, 11:28 am

Related News

  • 10 more Covid-19 cases reported in country
  • US Health Secretary Kennedy guts vaccine advisory committee
  • Govt plans to relocate country's first vaccine plant from Gopalganj to Munshiganj
  • Umrah pilgrims struggle with abrupt meningitis vaccination requirement amid shortage
  • Vaccination, early screening can prevent cervical cancer death for women

Incapacity to jab will limit Covid vaccination

“In the case of Covid-19 vaccination, Bangladesh will have to vaccinate approximately 162 million people rapidly, which would be extremely challenging with the existing immunisation programme”

Sadiqur Rahman
06 September, 2020, 11:00 pm
Last modified: 07 September, 2020, 11:28 am
Photo: Xinhua
Photo: Xinhua

Highlights

  1. The existing capacity only allows vaccination of around 4 million annually
  2. University of Birmingham, Heriot-Watt University, Brac University and Buet team up to design cold chain logistics for efficient mass vaccination for 162 million people

Even if Bangladesh gets required Covid-19 vaccines from Oxford University or other sources, can it vaccinate more than 162 million people within a year? The answer appears to be a 'no'.

For mass vaccination against the often lethal virus, the country needs to deliver vaccines to people countrywide at a scale and speed never thought before.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Every year, nearly four million children get antigens.

This is perhaps the maximum capacity of mass vaccination in the country.

It will require 10 years or more to bring all the population irrespective of ages under coverage if the mass vaccination begins with the existing capacity, say local experts.

That is why the whole immunisation programme needs to be re-engineered, particularly the cold chain which is mandatory to preserve the valuable vaccines, they add.  

Researchers at the University of Birmingham and Heriot-Watt University have collaborated with their counterparts at Brac University and Bangladesh University of Engineering and Technology (Buet) to assess the capacity and preparedness of Bangladesh's cold chain logistics.

The UK Research and Innovation is supporting the one and half year programme.

The outcome is expected to create a blueprint to help ensure a cost-effective model for blanket Covid-19 vaccination.

A cold chain is a temperature-controlled supply chain. To store, manage and transport life-saving vaccines, it takes a chain of precisely coordinated events, maintaining a desired low-temperature range.

Professor Farzana Munshi, an Economics teacher at the School of Humanities and Social Sciences of Brac University, has been working as a co-investigator under the project.

Farzana told The Business Standard, "The core element of the project is to evaluate the vaccine cold chain for mass scale Covid-19 vaccination in Bangladesh. It is crucial to assess the capacity and preparedness of the Covid-19 vaccination cold chain."

When the chief of the World Health Organisation (WHO) warns about Covid-19 vaccine nationalism, access to vaccines seems a major challenge for low-income countries lacking a robust refrigerated cooling system.

Although Bangladesh has one of the world's largest pharmaceutical and vaccine industries, with a vaccination framework supported by Gavi, the Vaccine Alliance, and the WHO, the country still lacks the capacity to deliver fast-track mass vaccination on an unprecedented scale.

Citing the WHO-2006 guidelines, Professor Farzana said the protocols for Covid-19 vaccine will require it to be kept in a narrow range between 2°C and 8°C, while in transport and storage. A thermally controlled envelope is required throughout the whole supply chain ranging from production to the final recipient of the vaccine.

With the country's current infrastructure, Bangladesh is able to deliver diphtheria, pertussis and tetanus (DPT) vaccines to 94% of the children. However, children below 14 years only accounted for around 27% or 44 million of the population in 2018.

"In the case of Covid-19 vaccination, Bangladesh will have to vaccinate approximately 162 million people rapidly, which would be extremely challenging with the existing immunisation programme," Farzana said.

According to Farzana, the project would assist policymakers in designing policies on the most sustainable interventions on the medical supply chain at regional, national scale for Covid-19 but also other potential future natural disasters and epidemics.

Cold chain is a crucial part of vaccination. Bangladesh still lacks sustainable cooling infrastructure and resilient electricity in rural communities.

Professor Ijaz Hossain, a chemical engineering teacher and dean of engineering at Buet, said "A cold chain covers a vast network combining refrigeration and storage facilities within central depots to grassroots distribution points and obviously the transportation. Lack of a sustainable cold chain will cause wastage and risk of less availability of vaccines from abroad."

In his opinion, Bangladesh's existing capacity of mass vaccination would be extremely inadequate to combat Covid-19. He will take part in designing the new cold chain after assessment of power availability and vaccine storage capacity at the grassroots.

On September 5, in a press release by the University of Birmingham, the project developer Toby Peters, also a Professor of Cold Economy at the university, commented, "Sustainable cold chain development will support Bangladesh's economy and help to support existing immunisation and cold chain programmes as well as a Covid-19 vaccine."

The project will help to design a roadmap for an efficient delivery mechanism to ensure that the vaccine will be provided globally, he added.

Researchers will also make their findings available to other countries in order to help public health planners evaluate their best options for creating sustainable temperature-controlled supply chains for health and medical supplies in epidemics and natural disasters, the release said.

Last month, the Bangladesh government gave the go-ahead for human trials of the Covid-19 vaccine developed by the Chinese company Sinovac Biotech.

The International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) and Sinovac will jointly conduct the trial. South Korea's LSK Global PS, a clinical research organisation, will monitor the trial data.

Top News

Coronavirus / Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Saifuzzaman Chowdhury. Photo: Collected
    UK crime agency now freezes assets of ex-land minister Saifuzzaman: AJ
  • Chief Adviser Muhammad Yunus speaks at the Chatham House in London on 11 June 2025. Photo: CA Press Wing
    No desire to be part of next elected govt: CA Yunus
  • File photo of BNP Standing Committee Member Amir Khasru Mahmud Chowdhury. Photo: Collected
    Khasru flies to London ahead of Yunus-Tarique meeting

MOST VIEWED

  • Illustration: Duniya Jahan/ TBS
    Forget Katy Perry, here’s Bangladesh’s Ruthba Yasmin shooting for the moon
  • A file photo of Bangladesh Bank Governor Dr Ahsan H Mansur. Photo: Collected
    'I have no relation with this': Ahsan Mansur debunks Joy’s allegations over daughter’s Dubai flat
  • Faiz Ahmad Tayeb. Photo: BSS
    Import duty on raw materials for e-bikes, lithium batteries reduced from 80% to 1% in some cases: Faiz Taiyeb
  • File photo of ex-prime minister Sheikh Hasina and her son Sajeeb Wazed Joy. Photo: Collected
    Joy spends Eid with Hasina in India: Indian media
  • Mercantile Bank withholds dividend amid Tk1,700cr provision shortfall
    Mercantile Bank withholds dividend amid Tk1,700cr provision shortfall
  • Shakil Ahmed. Photo: Collected
    DU student allegedly hangs himself following threats over old derogatory comment about Prophet on Facebook

Related News

  • 10 more Covid-19 cases reported in country
  • US Health Secretary Kennedy guts vaccine advisory committee
  • Govt plans to relocate country's first vaccine plant from Gopalganj to Munshiganj
  • Umrah pilgrims struggle with abrupt meningitis vaccination requirement amid shortage
  • Vaccination, early screening can prevent cervical cancer death for women

Features

Among pet birds in the country, lovebirds are the most common, and they are also the most numerous in the haat. Photo: Junayet Rashel

Where feathers meet fortune: How a small pigeon stall became Dhaka’s premiere bird market

8h | Panorama
Illustration: Duniya Jahan/ TBS

Forget Katy Perry, here’s Bangladesh’s Ruthba Yasmin shooting for the moon

1d | Features
File photo of Eid holidaymakers returning to the capital from their country homes/Rajib Dhar

Dhaka: The city we never want to return to, but always do

2d | Features
Photo collage shows political posters in Bagerhat. Photos: Jannatul Naym Pieal

From Sheikh Dynasty to sibling rivalry: Bagerhat signals a turning tide in local politics

4d | Bangladesh

More Videos from TBS

Why is Omicron XBB more contagious?

Why is Omicron XBB more contagious?

5h | TBS Stories
What did Dr. Yunus say at the Chatham House Dialogue in London?

What did Dr. Yunus say at the Chatham House Dialogue in London?

6h | TBS Today
News of The Day, 11 JUNE 2025

News of The Day, 11 JUNE 2025

7h | TBS News of the day
WB predicts worst decade for global growth since 60s

WB predicts worst decade for global growth since 60s

8h | TBS Stories
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net